Skip to main content

Flovent HFA News

Withdrawal of Flovent Led to Discontinuation of Inhaled Steroids for Children With Asthma

FRIDAY, May 2, 2025 – For children using fluticasone propionate, the withdrawal of the brand-name drug (Flovent) was associated with increased discontinuation of inhaled steroid therapy, according...

More Kids Without Asthma Inhaler After Flovent Taken Off Market

WEDNESDAY, April 30, 2025 — More children stopped using steroid inhalers to control their asthma after a manufacturer discontinued a popular inhaler, a new study says. In 2024, GlaxoSmithKline w...

Timing Might Be Everything With Asthma Inhalers

WEDNESDAY, April 16, 2025 – Folks with asthma might better control their symptoms by precisely timing when they use their inhaler, a new study says. A single daily preventive dose of inhaled...

Teva Announces FDA Approval of ArmonAir RespiClick (fluticasone propionate) for Maintenance Treatment of Asthma

JERUSALEM--(BUSINESS WIRE) January 30, 2017 --Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced that the U.S. Food and Drug Administration (FDA) has approved ArmonAir...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Eosinophilic Esophagitis, Asthma - Maintenance

Flovent HFA patient information at Drugs.com